Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations-Reference-Cited by-同舟云学术

Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations

Published:2020-11-25 Issue:1 Volume:15 Page:27-42
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Ogino Atsuko¹,Choi Jihyun¹,Lin Mika¹,Wilkens Margaret K.²,Calles Antonio¹^ORCID,Xu Man³,Adeni Anika E.¹,Chambers Emily S.¹,Capelletti Marzia¹,Butaney Mohit¹,Gray Nathanael S.⁴⁵,Gokhale Prafulla C.²,Palakurthi Sangeetha³,Kirschmeier Paul³,Oxnard Geoffrey R.¹⁶,Sholl Lynette M.⁷,Jänne Pasi A.¹³⁶^ORCID

Affiliation:

1. Department of Medical Oncology Dana‐Farber Cancer Institute Boston MA USA

2. Experimental Therapeutics Core Dana‐Farber Cancer Institute Boston MA USA

3. Belfer Center for Applied Cancer Science Dana‐Farber Cancer Institute Boston MA USA

4. Department of Biological Chemistry and Molecular Pharmacology Harvard Medical School Boston MA USA

5. Department of Cancer Biology Dana‐Farber Cancer Institute Boston MA USA

6. Lowe Center for Thoracic Oncology Dana‐Farber Cancer Institute Boston MA USA

7. Department of Pathology Brigham and Women’s Hospital Boston MA USA

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology